AstraZeneca to bring innovative medicines faster to India, says MD Panchal
The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...
The Manila Times3h
ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable ...